BIOC
$6.22
Biocept
($.26)
(4.01%)
BIOC
Earnings Whisper ®
N/A
2nd Quarter June 2018
Consensus:  ($3.30)
Revenue:  $1.33 Mil
Tuesday
Aug 14
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BIOC reports earnings?
Beat
Meet
Miss

Where is BIOC's stock price going from here?
Up
Flat
Down
Stock chart of BIOC
Analysts
Summary of analysts' recommendations for BIOC
Score
Grade
Pivots
Resistance
$6.98
$6.74
$6.48

$6.24

Support
$5.98
$5.74
$5.48
Tweet
Growth
Description
Biocept, Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept, Inc. is headquartered in San Diego, California.
Peers
Laboratory Corp. of America HoldingsQuest Diagnostics